The HIV prevention field in Canada has failed to achieve a stabilising point, a lack of consensus on the effectiveness of risk management strategies, in its third decade, the transition to the biomedical era of HIV prevention. Under these conditions of uncertainty we have witnessed epistemic and social and political uncertainties proliferate. Experts debate long-standing and emerging prevention strategies. Newly produced knowledge complicates our understanding of gay male HIV prevention but often lacks appropriate validity and generalizability. Governing practices are implemented to respond to this knowledge, but in conflicting ways. For everyday social actors, these uncertainties morph into complicated forms of experiential uncertainty. ...
This paper examines the risk discourses of Sydney gay men who had recently become HIV positive. 92 i...
Background: After 3 decades of research and programming for MSM, in 2014, HIV remains a major public...
IntroductionNotwithstanding the efficacy of oral preâ exposure prophylaxis (PrEP) in clinical trial...
Modern society has been termed a 'risk-society', one in which risks are produced and become incorpor...
Evidence of the efficacy of HIV treatment as prevention (TasP) precipitated a highly optimistic glob...
This paper examines the ways in which populations at risk of HIV in the developed world have encultu...
Pre-exposure prophylaxis (PrEP) to HIV is a promising yet controversial new technology in the biomed...
A recent multi-country study on hormonal contraceptives (HC) and HIV acquisition and transmission am...
BACKGROUND:: Measures of HIV treatments optimism were developed in response to increased risk behavi...
BACKGROUND: The fact that HIV prevention often deals with politicised sexual and drug taking behavio...
This article examines narratives about promiscuity that are emphasized by some gay and bisexual men ...
Based on interviews with 34 men, almost all of whom have unprotected sex with men most or all of the...
Highly Active Anti-Retroviral Treatment (HAART) has reduced death and morbidity among people with HI...
This paper examines the sometimes implicit models of human behaviour circulating in science, governm...
OBJECTIVES: The INSIGHT case-control study confirmed that HIV serodiscordant unprotected anal interc...
This paper examines the risk discourses of Sydney gay men who had recently become HIV positive. 92 i...
Background: After 3 decades of research and programming for MSM, in 2014, HIV remains a major public...
IntroductionNotwithstanding the efficacy of oral preâ exposure prophylaxis (PrEP) in clinical trial...
Modern society has been termed a 'risk-society', one in which risks are produced and become incorpor...
Evidence of the efficacy of HIV treatment as prevention (TasP) precipitated a highly optimistic glob...
This paper examines the ways in which populations at risk of HIV in the developed world have encultu...
Pre-exposure prophylaxis (PrEP) to HIV is a promising yet controversial new technology in the biomed...
A recent multi-country study on hormonal contraceptives (HC) and HIV acquisition and transmission am...
BACKGROUND:: Measures of HIV treatments optimism were developed in response to increased risk behavi...
BACKGROUND: The fact that HIV prevention often deals with politicised sexual and drug taking behavio...
This article examines narratives about promiscuity that are emphasized by some gay and bisexual men ...
Based on interviews with 34 men, almost all of whom have unprotected sex with men most or all of the...
Highly Active Anti-Retroviral Treatment (HAART) has reduced death and morbidity among people with HI...
This paper examines the sometimes implicit models of human behaviour circulating in science, governm...
OBJECTIVES: The INSIGHT case-control study confirmed that HIV serodiscordant unprotected anal interc...
This paper examines the risk discourses of Sydney gay men who had recently become HIV positive. 92 i...
Background: After 3 decades of research and programming for MSM, in 2014, HIV remains a major public...
IntroductionNotwithstanding the efficacy of oral preâ exposure prophylaxis (PrEP) in clinical trial...